Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06993753
What this trial is testing

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Viral (RSV) Infections
Griffith University 4,350
Testing effectiveness (Phase 2)Study completedNCT01502072
What this trial is testing

Respiratory Syncytial Virus - RSV Protocol

Who this might be right for
Bone Marrow Transplant InfectionInfection in Marrow Transplant RecipientsRespiratory Syncytial Virus Infections+3 more
M.D. Anderson Cancer Center 48
Early research (Phase 1)Study completedNCT01556607
What this trial is testing

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma

Who this might be right for
Drug Safety
MicroDose Therapeutx, Inc 10
Large-scale testing (Phase 3)Looking for participantsNCT07658534
What this trial is testing

Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 290
Testing effectiveness (Phase 2)Study completedNCT05886777
What this trial is testing

Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).

Who this might be right for
Healthy Participants
Pfizer 1,142
Testing effectiveness (Phase 2)Looking for participantsNCT06597916
What this trial is testing

RSV Vaccination in Immunocompromised Patients.

Who this might be right for
RSV Infection
Medical University of Vienna 200
Testing effectiveness (Phase 2)Ended earlyNCT04633187
What this trial is testing

Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract

Who this might be right for
Respiratory Syncytial Virus Infections
Enanta Pharmaceuticals, Inc 9
Testing effectiveness (Phase 2)Study completedNCT03814590
What this trial is testing

Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,053
Not applicableStudy completedNCT06207929
What this trial is testing

Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections

Who this might be right for
Influenza, HumanCOVID-19Influenza A+2 more
Evidation Health 18,157
Large-scale testing (Phase 3)Looking for participantsNCT06363370
What this trial is testing

Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

Who this might be right for
Respiratory Syncytial Virus Infections
Kexing Biopharm Co., Ltd. 322
Testing effectiveness (Phase 2)Study completedNCT02927873
What this trial is testing

Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 107
Early research (Phase 1)Study completedNCT00345670
What this trial is testing

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Who this might be right for
Healthy
MedImmune LLC 120
Testing effectiveness (Phase 2)Study completedNCT06251024
What this trial is testing

Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 4,541
Large-scale testing (Phase 3)Study completedNCT06374394
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 841
Early research (Phase 1)Looking for participantsNCT06843317
What this trial is testing

Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults

Who this might be right for
RSV Infection
Clover Biopharmaceuticals USA, LLC 160
Large-scale testing (Phase 3)Study completedNCT06593587
What this trial is testing

Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea

Who this might be right for
Respiratory Syncytial Virus
Pfizer 378
Testing effectiveness (Phase 2)Study completedNCT04196101
What this trial is testing

Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects

Who this might be right for
Respiratory Syncytial Virus
Enanta Pharmaceuticals, Inc 82
Large-scale testing (Phase 3)Study completedNCT06067230
What this trial is testing

Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 1,153
Testing effectiveness (Phase 2)Study completedNCT00632463
What this trial is testing

RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

Who this might be right for
Upper Respiratory Tract InfectionLower Respiratory Tract Infection
ADMA Biologics, Inc. 21
Not applicableStudy completedNCT02755948
What this trial is testing

Cell Mediated Immunity Against RSV and Influenza in a Human Experimental Challenge

Who this might be right for
Respiratory Syncytial Virus InfectionsInfluenza, Human
Imperial College London 75
Next Page